What's New with Roche Pathology Lab

Our mission is to improve the lives of all patients with cancer. Roche is investing in every step of the patient journey to meet the evolving needs of labs and patients.

Roche receives FDA clearance on its digital pathology solution for diagnostic use

Roche announced today that its whole slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the FDA. The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose patients.

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

Roche announced today FDA approval of Alecensa^® (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours ≥ 4 cm or node positive), as detected by an FDA-approved test.

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer

Roche announced today the FDA approval of its human papillomavirus (HPV) self-collection solution, the first available in the United States.

Roche's Digital Pathology Open Environment

Roche Digital Pathology expands its commitment to improving patient outcomes and advancing personalized healthcare enabled by open environment innovation.